Advertisement

Promethazine Injection

[08 July 2015]

Products Affected - Description

Promethazine solution for injection, Hospira
25 mg/mL 1 mL Carpuject syringe, 10 count (NDC 00409-2312-31)
 
Promethazine solution for injection, Teva
25 mg/mL 1 mL vial, 25 count (NDC 00703-2191-04)
50 mg/mL 1 mL vial, 25 count (NDC 00703-2201-04)
 
Promethazine solution for injection, West-Ward
25 mg/mL 1 mL vial, 25 count (NDC 00641-0928-25)
25 mg/mL 1 mL ampule, 25 count (NDC 00641-1495-35)
50 mg/mL 1 mL ampule, 25 count (NDC 00641-1496-35)
 
Phenergan solution for injection, West-Ward
25 mg/mL 1 mL ampule, 25 count (NDC 00641-6082-25)
50 mg/mL 1 mL ampule, 25 count (NDC 00641-6083-25)

Promethazine solution for injection, X-Gen
25 mg/mL 1 mL ampule, 25 count (NDC 39822-5500-03)

Reason for the Shortage

  • Teva states the shortage is due to manufacturing delays.
  • West-Ward states the shortage was due to manufacturing delays.
  • Hospira states the shortage is due to manufacturing delays.

Available Products

Promethazine solution for injection, West-Ward
50 mg/mL 1 mL vial, 25 count (NDC 00641-0929-25)

Phenergan solution for injection, West-Ward
25 mg/mL 1 mL vial, 25 count (NDC 00641-6084-25)
50 mg/mL 1 mL vial, 25 count (NDC 00641-6085-25)
 
Promethazine solution for injection, X-Gen
50 mg/mL 1 mL ampule, 25 count (NDC 39822-5500-06)

Estimated Resupply Dates

  • Hospira has promethazine 25 mg/mL 1 mL Carpuject syringes on back order and the company cannot estimate a release date.
  • Teva has all promethazine injection presentations on back order and the company estimates a release date of July 2016.
  • West-Ward has promethazine 25 mg/mL 1 mL ampules and 50 mg/mL 1 mL ampules on back order and the company cannot estimate a release date. Promethazine 25 mg/mL 1 mL vials are available with short expiration dating (November 2015). Promethazine 50 mg/mL 1 mL vials are available with both regular and short expiration dating (April 2016).
  • West-Ward has Phenergan 50 mg/mL 1 mL ampules available with short expiration dating (October 2015). Phenergan 25 mg/mL 1 mL ampules in 25 count are on back order and the company cannot estimate a release date.
    X-Gen has promethazine 25 mg/mL 1 mL ampules on back order and the company cannot estimate a release date.

Related Shortages

Updated

July 8, June 1, May 4, April 3, March 9, February 2, January 12, 2015; December 1, November 6, 10, and 19, October 1, August 28, July 10 and 31, May 6, April 10 and 23, March 27, January 24, 2014; November 11, September 18, August 15, July 3 and 8, June 11, April 30, March 6 and 26, February 13 and 20, January 18, 25, and 30, 2013; November 9 and 28, September 7, August 13, July 20, June 21, May 7, March 9 and 21, February 10, January 6 and 24, 2012; December 9, November 9, 23, and 30, September 6, July 15, May 24, April 6, March 1 and 18, February 9, January 27, 2011; December 1 and 15, November 4, October 1 and 14, September 9, August 18 and 31, July 30, June 22, 2010, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement